info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Allergy Vaccine Companies

Allergy vaccines, also known as allergen immunotherapy, involve the administration of gradually increasing doses of specific allergens to desensitize the immune system and reduce allergic reactions. Companies involved in allergy vaccines operate in the pharmaceutical and biotechnology sectors, focusing on the development and manufacturing of immunotherapeutic products for allergy treatment.

Allergy Vaccine Companies

 


Latest Allergy Vaccine Companies Update:

Merck Sharp & Dohme (MSD) Acquired Aimmune Therapeutics, gaining access to their peanut allergy vaccine, Palforzia, and strengthening their allergy treatment portfolio.


ALK-Abello Partnered with Regeneron on their investigational IL-4Rα antagonist, REGN1679, to explore its potential in treating severe allergic diseases.


Circassia Pharmaceuticals Received FDA approval for their grass pollen sublingual tablet allergy vaccine, Grazax®, expanding access to this treatment option.


Stallergenes Greer Launched their first sublingual tablet allergy vaccine for ragweed in the US, Oralair® (ambrosia artemisiifolia sublingual allergenic extract), further diversifying their product portfolio.


Immuno Laboratories Developed the Viaskin® Peanut, a next-generation epicutaneous allergy patch for peanut allergies, currently undergoing Phase 3 clinical trials.


LEO Pharma Announced positive Phase 2b results for their investigational peanut allergy patch, Omalizumab, demonstrating potential for future market entry.


List of Allergy Vaccine companies in the market


  • ALK (Denmark)




  • Stallergenes Greer (Switzerland)




  • Allergy Therapeutics (U.K.)




  • HAL Allergy B.V. (Netherlands)




  • HollisterStier Allergy (U.S.)




  • Zhejiang Wolwo Bio-pharmaceutical Co., Ltd (China)




  • LETIPharma (Spain)




  • Dermapharm Holding SE (Germany)




Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.